Immunology Investor Event

Dupixent: Eosinophilic Esophagitis 12+ Treated Number of patients (thousands) 159 Severe 48 49 97 0 20 40 40 Source: Sanofi analysis PPI Proton pump inhibitor (1) Germany, France, Italy, Spain & United Kingdom 17 Immunology Investor Event 161 320 T 60 60 80 100 120 140 160 180 200 220 240 260 280 300 320 US Europe(1) Uncontrolled on high dose PPI and topical steroid slurry sanofi

View entire presentation